The Burden of Neuropsychiatric Disorders in Medicaid Patients Living With HIV-1 Treated With Integrase Inhibitor or Protease Inhibitor Antiretroviral Therapies
The Primary Care Companion For CNS Disorders · 2023
DOI: 10.4088/pcc.22m03374 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Primary Care Companion For CNS Disorders, 2023. Verfasst von Ji Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Janssen Scientific Affairs, LLC, Titusville, New Jersey. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV-1, HIV Infections.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Janssen Scientific Affairs, LLC, Titusville, New Jersey.
- Corresponding author: Ji Song, PhD, 1125 Trenton-Harbourton Rd, Titusville, NJ 08560 (JSong59@its.jnj.com).
- Now with Gilead Sciences, Inc, Foster City, California.
Zitieren
APA
Song, J., Donga, P., Holt, J., Rogers, R., & Wu, B. (2023). The Burden of Neuropsychiatric Disorders in Medicaid Patients Living With HIV-1 Treated With Integrase Inhibitor or Protease Inhibitor Antiretroviral Therapies. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.22m03374
Vancouver
Song J, Donga P, Holt J, Rogers R, Wu B. The Burden of Neuropsychiatric Disorders in Medicaid Patients Living With HIV-1 Treated With Integrase Inhibitor or Protease Inhibitor Antiretroviral Therapies. The Primary Care Companion For CNS Disorders. 2023. doi:10.4088/pcc.22m03374
BibTeX
@article{Song2023,
author = {Song, Ji and Donga, Prina and Holt, Jessica and Rogers, Rachel and Wu, Bingcao},
title = {The Burden of Neuropsychiatric Disorders in Medicaid Patients Living With HIV-1 Treated With Integrase Inhibitor or Protease Inhibitor Antiretroviral Therapies},
journal = {The Primary Care Companion For CNS Disorders},
year = {2023},
doi = {10.4088/pcc.22m03374}
}
EUVIMED